Market revenue in 2023 | USD 31.6 million |
Market revenue in 2030 | USD 84.5 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Other Ablation Technologies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.49% in 2023. Horizon Databook has segmented the Argentina tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare spending in Argentina accounts for approximately 7% of the total GDP. In this country, 70% to 75% of medical products are imported. The U.S. exports medical devices to Argentina as the country has the most technologically advanced products. Argentina remains a key market in Latin America in the U.S.
The U.S. is one of Argentina's noteworthy exporters and is among the three best FDI source countries. Imports of medical products must be performed by an importer registered with Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT), the Argentine equivalent to the U.S. FDA, as a frequent importer of medical devices.
Furthermore, collaborations between Argentine research institutions and international partners facilitate knowledge exchange and access to state-of-the-art imaging technologies, contributing to advancements in tumor ablation procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into Argentina tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account